VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Germline von Hippel-Lindau tumour suppressor gene (VHL) mutations cause renal cell carcinomas, haemangioblastomas and phaeochromocytomas in humans. Mutations in VHL also occur in sporadic renal cell carcinomas. The protein encoded by VHL, VHL, is part of the ubiquitin ligase that downregulates the heterodimeric transcription factor Hif under well-oxygenated conditions. Here we show that acute VHL inactivation causes a senescent-like phenotype in vitro and in vivo. This phenotype was independent of p53 and Hif but dependent on the retinoblastoma protein (Rb) and the SWI2/SNF2 chromatin remodeller p400. Rb activation occurred through a decrease in Skp2 messenger RNA, which resulted in the upregulation of p27 in a Hif-independent fashion. Our results suggest that senescence induced by VHL inactivation is a tumour-suppressive mechanism that must be overcome to develop VHL-associated neoplasias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One recent example supports this model: loss of function of the Von Hippel Lindau (VHL) tumour suppressor creates an oncogenic stress that triggers a senescence response both in vitro and in vivo.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [128]
In the citing paper
“This senescent cell cycle arrest depends on the presence of functional RB128 and is in part mediated by the RB–SKP2 (S-phase kinase-associated protein 2)–p27 pathway.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [128]
In the citing paper
“This senescent cell cycle arrest depends on the presence of functional RB128 and is in part mediated by the RB–SKP2 (S-phase kinase-associated protein 2)–p27 pathway.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [128]
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Hayashi, S., & McMahon, A. P. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0597 · Cited by 1,342
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
Research works printed but not linked: 1
- Hayashi, S. & McMahon, A. P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244, 305–318 (2002). · DOI · Paper page
Cited by
Items 101–200 of 279
Knockdown of AGR2 induces cellular senescence in prostate cancer cells
Hu, Z., Gu, Y., Han, B., Zhang, J., Li, Z., Tian, K., Young, C. Y. F., & Yuan, H. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs141 · Cited by 49
Gupta, S., Silveira, D. A., & Mombach, J. C. M. (2019) · FEBS Letters · doi:10.1002/1873-3468.13615 · Cited by 49
Laine, A., & Westermarck, J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1942 · Cited by 36
The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis
Hudler, P., & Urbančič, M. (2022) · Genes · doi:10.3390/genes13020362 · Cited by 47
Genome-wide mapping of Hif-1α binding sites in zebrafish
Greenald, D., Jeyakani, J., Pelster, B., Sealy, I. M., Mathavan, S., & van Eeden, F. J. (2015) · BMC Genomics · doi:10.1186/s12864-015-2169-x · Cited by 46
SCFβ-TRCP promotes cell growth by targeting PR-Set7/Set8 for degradation
Wang, Z. P., Dai, X., Zhong, J., Inuzuka, H., Wan, L., Li, X., Wang, L., Ye, X., Sun, L., Gao, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms10185 · Cited by 44
Welford, S. M., Dorie, M. J., Li, X., Haase, V. H., & Giaccia, A. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01618-09 · Cited by 40
Laphanuwat, P., Likasitwatanakul, P., Sittithumcharee, G., Thaphaengphan, A., Chomanee, N., Suppramote, O., Ketaroonrut, N., Charngkaew, K., Lam, E. W. ‐., Okada, S., et al. (2018) · Journal of Cell Science · doi:10.1242/jcs.214726 · Cited by 43
Grillari, J., Grillari‐Voglauer, R., & Jansen‐Dürr, P. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7002-2_13 · Cited by 43
Senescence and pre-malignancy: How do tumors progress?
Saab, R. H. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.013 · Cited by 42
Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex
Wu, J., Lee, S.-W., Zhang, X., Han, F., Kwan, S.-Y., Yuan, X., Yang, W.-L., Jeong, Y., Rezaeian, A.-H., Gao, Y., et al. (2012) · Oncogene · doi:10.1038/onc.2012.26 · Cited by 42
Li, S., Li, W., Yuan, J., Bullova, P., Wu, J., Zhang, X., Liu, Y., Plescher, M., Rodríguez, J., Bedoya-Reina, O. C., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00593-x · Cited by 38
Self-citationRenal cancer: Oxygen meets metabolism
Haase, V. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.026 · Cited by 38
Schlisio, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00881.x · Cited by 38
Self-citationMangiavini, L., Merceron, C., Araldi, E., Khatri, R., Gerard-O’Riley, R. L., Wilson, T. L., Rankin, E. B., Giaccia, A. J., & Schipani, E. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.06.013 · Cited by 38
The E1A-Associated p400 Protein Modulates Cell Fate Decisions by the Regulation of ROS Homeostasis
Mattera, L., Courilleau, C., Legube, G., Ueda, T., Fukunaga, R., Chevillard, M., Canitrot, Y., Escaffit, F., & Trouche, D. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000983 · Cited by 38
Cole, A. M., Ridgway, R. A., Derkits, S. E., Parry, L., Barker, N., Clevers, H., Clarke, A. R., & Sansom, O. J. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000101 · Cited by 37
Cheng, L., Williamson, S. R., Zhang, S., MacLennan, G. T., Montironi, R., & López-Beltrán, A. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.72 · Cited by 38
Das, F., Dey, N., Bera, A., Kasinath, B. S., Ghosh‐Choudhury, N., & Choudhury, G. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.694331 · Cited by 37
Kitajima, S., Miki, T., Takegami, Y., Kido, Y., Noda, M., Hara, E., Shamma, A., & Takahashi, C. (2010) · Oncogene · doi:10.1038/onc.2010.448 · Cited by 37
Acute Vhl Gene Inactivation Induces Cardiac HIF-Dependent Erythropoietin Gene Expression
Marta, M.-M., Elorza, A., Soro-Arnáiz, I., Albacete-Albacete, L., Ordóñez, Á., Balsa, E., Vara-Vega, A., Vázquez, S., Esther, F., Carmen, F.-C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022589 · Cited by 37
Xi, H., Gao, Y., Han, D., Li, Q., Feng, L.-J., Zhang, W., Ji, G., Xiao, J., Zhang, H., & Wei, Q. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.07.030 · Cited by 36
Macklin, P. S., Yamamoto, A., Browning, L., Hofer, M., Adam, J., & Pugh, C. W. (2020) · The Journal of Pathology · doi:10.1002/path.5402 · Cited by 35
Structure and Function of the Ubiquitin–Proteasome System
Chondrogianni, N., & Gonos, E. S. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00002-x · Cited by 34
The dual role of cellular senescence in human tumor progression and therapy
Ma, L., Yu, J., Fu, Y., He, X., Ge, S., Jia, R., Zhuang, A., Yang, Z. H., & Fan, X. (2024) · MedComm · doi:10.1002/mco2.695 · Cited by 33
Une re-vue de la sénescence cellulaire: Ami ou ennemi de la promotion tumorale ?
Bischof, O., Dejean, A., & Pineau, P. (2009) · médecine/sciences · doi:10.1051/medsci/2009252153 · Cited by 32
A Zebrafish Model for VHL and Hypoxia Signaling
van Rooijen, E., Santhakumar, K., Logister, I., Voest, E. E., Schulte‐Merker, S., Giles, R. H., & Eeden, F. V. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-381320-6.00007-2 · Cited by 32
Minervini, G., Quaglia, F., Tabaro, F., & Tosatto, S. C. E. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006478 · Cited by 31
Regulation of cellular senescence by microRNAs
Ma, X., Zheng, Q., Zhao, G., Yuan, W., & Liu, W. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111264 · Cited by 30
Schönenberger, D., Rajski, M., Harlander, S., & Frew, I. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11275 · Cited by 30
Bangiyeva, V., Rosenbloom, A., Alexander, A. E., Isanova, B., Popko, T., & Schoenfeld, A. R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-229 · Cited by 30
Novel ARF/p53-independent senescence pathways in cancer repression
Chan, C., Gao, Y., Moten, A., & Lin, H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0766-y · Cited by 29
Oncogene-Induced Senescence and its Role in Tumor Suppression
Reddy, J. P., & Li, Y. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9221-5 · Cited by 29
Tennenbaum, D. M., Manley, B. J., Zabor, E. C., Becerra, M. F., Carlo, M. I., Casuscelli, J., Redzematovic, A., Khan, N. A., Arcila, M. E., Voss, M. H., et al. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.03.015 · Cited by 29
TASK-3 Downregulation Triggers Cellular Senescence and Growth Inhibition in Breast Cancer Cell Lines
Zúñiga, R., Valenzuela, C. A., Concha, G., Brown, N. E., & Zúñiga, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041033 · Cited by 27
Ram, R. R., Mendiratta, S., Bodemann, B. O., Torres, M. J., Eskiocak, U., & White, M. A. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01506-13 · Cited by 26
Senescence-associated protein p400 is a prognostic marker in renal cell carcinoma
Macher‐Goeppinger, S., Bermejo, J. L., Schirmacher, P., Pahernik, S. A., Hohenfellner, M., & Roth, W. (2013) · Oncology Reports · doi:10.3892/or.2013.2698 · Cited by 26
Drosophila von Hippel-Lindau Tumor Suppressor Gene Function in Epithelial Tubule Morphogenesis
Hsouna, A., Nallamothu, G., Kose, N., Guinea, M., Dammai, V., & Hsu, T. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01578-09 · Cited by 26
Senescence of human skin-derived precursors regulated by Akt-FOXO3-p27KIP1/p15INK4b signaling
Liu, S., Wang, X., Zhao, Q., Liu, S., Zhang, H., Shi, J., Li, N., Lei, X., Zhao, H., Deng, Z., et al. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1877-3 · Cited by 25
Chakraborty, A. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.012 · Cited by 25
Unraveling Adipocytes and Cancer Links: Is There a Role for Senescence?
Wu, Q., Li, B., Sun, S., & Sun, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00282 · Cited by 24
Rb1/Rbl1/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma
Wei, R., Ren, X., Kong, H., Lv, Z., Chen, Y., Tang, Y., Wang, Y., Xiao, L., Yu, T., Hacibekiroglu, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127889 · Cited by 24
Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK/p27KIP1/pRB pathway
An, H., Ryu, M., Jeong, H. J., Kang, M., Jeon, H.-M., Lee, J., Kim, Y. S., & Lee, H. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.07.007 · Cited by 24
Duchi, S., Fagnocchi, L., Cavaliere, V., Hsouna, A., Gargiulo, G., & Hsu, T. (2010) · Development · doi:10.1242/dev.042804 · Cited by 24
Von Hippel-Lindau syndrome: molecular mechanisms of the disease
Calzada, M. J. (2010) · Clinical & Translational Oncology · doi:10.1007/s12094-010-0485-9 · Cited by 23
Duan, Y., Pan, J., Chen, J., Zhu, D., Wang, J., Sun, X., Chen, L., & Wu, L. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005268 · Cited by 22
Li, S., Rodríguez, J., Li, W., Bullova, P., Fell, S. M., Surova, O. V., Westerlund, I., Topcic, D., Bergsland, M., Stenman, A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900748116 · Cited by 22
Self-citationWang, H.-H., Lee, Y., Su, C., Shu, K.-T., Liu, W., Hsieh, C., Yeh, H., & Wu, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-63716-y · Cited by 21
Millán‐Uclés, Á., Castro, B. D., García‐Flores, P., Báez, A., Pérez‐Simón, J. A., López‐Barneo, J., & Piruat, J. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085528 · Cited by 21
PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma
Walton, J., Ng, A. S. N., Arevalo, K., Apostoli, A. J., Meens, J., Karamboulas, C., St‐Germain, J. R., Prinos, P., Dmytryshyn, J., Chen, E. X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52507-y · Cited by 20
McFarlane, M., Almire, F., Kean, J., Donald, C. L., McDonald, A., Wee, B. A., Lauréti, M., Varjak, M., Terry, S., Vazeille, M., et al. (2020) · mSphere · doi:10.1128/msphere.00081-20 · Cited by 20
Lee, K., Lau, Z. Z., Meredith, C., & Park, J. H. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.11.001 · Cited by 20
Pyruvate as a Pivot Point for Oncogene-Induced Senescence
Olenchock, B. A., & Heiden, M. G. V. (2013) · Cell · doi:10.1016/j.cell.2013.06.001 · Cited by 20
Lin, P., Mobasher, M. E., & Alawi, F. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.114 · Cited by 20
Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies
Kohno, S., Kitajima, S., Sasaki, N., & Takahashi, C. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i4.170 · Cited by 19
Cheng, Y., Chiang, H.-Y., Cheng, S.-J., Chang, H.-W., Li, Y., & Shieh, S.-Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03248-5 · Cited by 19
Genes and pathways involved in senescence bypass identified by functional genetic screens
Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 19
Review article: How cells sense oxygen: Lessons from and for the kidney
Gleadle, J. (2009) · Nephrology · doi:10.1111/j.1440-1797.2008.01064.x · Cited by 19
Cellular Senescence in Renal and Urinary Tract Disorders
Santin, Y., Lluel, P., Rischmann, P., Gamé, X., Mialet‐Perez, J., & Parini, A. (2020) · Cells · doi:10.3390/cells9112420 · Cited by 17
Mans, D. A., Vermaat, J. S. P., Weijts, B. G. M. W., van Rooijen, E., van Reeuwijk, J., Boldt, K., Daenen, L. G. M., van der Groep, P., Rowland, B. D., Jans, J. J. M., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4219 · Cited by 17
Frew, I. J., Smole, Z., Thoma, C. R., & Krek, W. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.024 · Cited by 17
VHL Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 Screens
Sun, N., Petiwala, S. M., Lu, C., Hutti, J. E., Hu, M., Hu, M., Domanus, M. H., Mitra, D., Addo, S. N., Miller, C. P., et al. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0018 · Cited by 17
Succoio, M., Comegna, M., DˈAmbrosio, C., Scaloni, A., Cimino, F., & Faraonio, R. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.07.010 · Cited by 17
VHL Deletion Impairs Mammary Alveologenesis but Is Not Sufficient for Mammary Tumorigenesis
Seagroves, T. N., Peacock, D. L., Liao, D., Schwab, L. P., Krueger, R. L., Handorf, C. R., Haase, V. H., & Johnson, R. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090310 · Cited by 16
Cellular Senescence and Anti-Cancer Therapy
You, J., Dong, R., Ying, M., He, Q., Cao, J., & Yang, B. (2018) · Current Drug Targets · doi:10.2174/1389450120666181217100833 · Cited by 16
Oxygen regulates molecular mechanisms of cancer progression and metastasis
Gupta, K., Madan, E., Sayyid, M. M., Arias‐Pulido, H., Moreno, E., Kuppusamy, P., & Gogna, R. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9464-2 · Cited by 16
Giovos, G., Yavropoulou, M. P., & Yovos, J. G. (2019) · HORMONES · doi:10.1007/s42000-019-00132-6 · Cited by 17
Senescence triggered by the loss of the VHL tumor suppressor
Young, A. P., & Kaelin, W. G. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6124 · Cited by 16
Self-citationCellular Senescence: Many Roads, One Final Destination
Saab, R. H. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.68 · Cited by 16
Wang, T., Wagner, R. T., Hlady, R. A., Pan, X., Zhao, X., Kim, S., Wang, L., Lee, J., Luo, H., Castle, E. P., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13487 · Cited by 15
Jung, Y., Chun, H.-Y., Yoon, M.-H., & Park, B.-J. (2014) · Neoplasia · doi:10.1016/j.neo.2014.09.013 · Cited by 15
Francica, P., Aebersold, D. M., & Medová, M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.022 · Cited by 15
A review on transcriptional regulation responses to hypoxia in mesenchymal stem cells
Alijani, N., Johari, B., Moradi, M., & Kadivar, M. (2019) · Cell Biology International · doi:10.1002/cbin.11211 · Cited by 15
Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid
Berardi, D. E., Flumián, C., Campodónico, P. B., Urtreger, A. J., Bessone, M. I. D., Motter, A. N., Joffé, E. B. D. K., Farias, E., & Todaro, L. B. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0230-z · Cited by 15
Renal Cell Carcinoma Deep Sequencing: Recent Developments
Farber, L. J., Furge, K., & Teh, B. T. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0230-3 · Cited by 14
Roles of Protein Post-Translational Modifications During Adipocyte Senescence
Hwang, M.-S., Park, J., Ham, Y., Lee, I. H., & Chun, K. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.86404 · Cited by 13
Altered stoichiometry and nuclear delocalization of NonO and PSF promote cellular senescence
Huang, C.-J., Das, U., Xie, W., Ducasse, M., & Tucker, H. O. (2016) · Aging · doi:10.18632/aging.101125 · Cited by 13
Hou, W., Kaczorowski, A., Lantwin, P., Kippenberger, M., Schütz, V., Franke, D., Dieffenbacher, S., Hohenfellner, M., & Duensing, S. M. (2020) · Pathobiology · doi:10.1159/000506709 · Cited by 13
VHL loss enhances antitumor immunity by activating the anti-viral DNA-sensing pathway
Jiao, M., Hu, M., Pan, D., Liu, X., Bao, X., Kim, J., Li, F., & Li, C. (2024) · iScience · doi:10.1016/j.isci.2024.110285 · Cited by 12
VCP/p97 increases BMP signaling by accelerating ubiquitin ligase Smurf1 degradation
Bailin, P. L., Cui, Y., Wei, J., Liu, C., Chen, Y., Cui, C., Li, L., Zhang, X., & Zhang, L. (2018) · The FASEB Journal · doi:10.1096/fj.201801173r · Cited by 12
Self-citationZhu, S., Xing, C., Zhang, G., Peng, H., & Wang, Z. (2021) · American Journal of Translational Research · Cited by 11
Mangiavini, L., Merceron, C., Araldi, E., Khatri, R., Gerard-O’Riley, R. L., Wilson, T. L., Sandusky, G. E., Abadie, J., Lyons, K. M., Giaccia, A. J., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.07.008 · Cited by 11
VHL and PTEN loss coordinate to promote mouse liver vascular lesions
Chen, S., Sanford, C. A., Sun, J., Choi, V. W., Dyke, T. V., Samulski, R. J., & Rathmell, W. K. (2010) · Angiogenesis · doi:10.1007/s10456-010-9164-2 · Cited by 11
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · Inside the Cell · doi:10.1002/icl3.1046 · Cited by 11
VHL Inactivation: A New Road to Senescence
Kim, W. Y., & Sharpless, N. E. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.012 · Cited by 11
Zalzali, H., Harajly, M., Abdul-Latif, L., El-Chaar, N. N., Dbaibo, G. S., Skapek, S. X., & Saab, R. H. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-28 · Cited by 11
Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinoma
Lee, C., & Motzer, R. J. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.10.012 · Cited by 10
Minervini, G., Lopreiato, R., Bortolotto, R., Falconieri, A., Sartori, G., & Tosatto, S. C. E. (2017) · Scientific Reports · doi:10.1038/srep46562 · Cited by 10
A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle
Zheng, N., Dai, X., Wang, Z. P., & Wei, W. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1234552 · Cited by 10
pVHL acts as a downstream target of E2F1 to suppress E2F1 activity
Ji, W., Wang, J., Zhang, W., Liu, X., Ouyang, G., & Xiao, W. (2013) · Biochemical Journal · doi:10.1042/bj20130793 · Cited by 8
HIF Pathways in Clear Cell Renal Cancer
Lombardi, O., & Mole, D. R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96539 · Cited by 6
A novel VHLα isoform inhibits Warburg effect via modulation of PKM splicing
Liu, Y., Yang, H., Li, L., Chen, S., Zuo, F., & Chen, L. (2016) · Tumor Biology · doi:10.1007/s13277-016-5191-y · Cited by 6
Self-citationMechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities
Ge, J., Hirosue, S., Castillon, L., Patel, S. A., Wesolowski, L., Dyas, A., Yong, C., de Haan, S., Drost, J., Stewart, G. D., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00361-w · Cited by 5
Subcellular Dynamics of The VHL Tumor Suppressor: On The Move for HIF Degradation
Khacho, M., & Lee, S. (2009) · Future Oncology · doi:10.2217/14796694.5.1.85 · Cited by 5
Microtubule dynamics is a therapeutic vulnerability in VHL-deficient renal cell carcinoma
Pu, Y., Wang, Z., Tao, S., Yang, E. J., Wu, S., Ren, G., Chen, L., Zhang, X., Tan, K., Dang, Y., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.109642 · Cited by 4
Mohanty, S. K., Veerabhadrappa, B., Majhi, A., Suchiang, K., & Dyavaiah, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00003-7 · Cited by 4
Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques
Pratsinis, H., Mavrogonatou, E., Zervou, S., Triantis, T. M., Hiskia, A. E., & Kletsas, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_19 · Cited by 4
Lazorthes, S., Vallot, C., Briois, S., Aguirrebengoa, M., Thuret, J., Laurent, G. S., Rougeulle, C., Kapranov, P., Mann, C., Trouche, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms7918 · Cited by 4
Meng, L., Zhang, H., Qiu, Y., Zhu, X., Ji, X., Wang, B., Zhang, G., Xue, Y., & Wang, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1727099 · Cited by 3
Netti, G. S., Spadaccino, F., Lucarelli, G. T., Catalano, V., Checchia, A. A., Stasi, A., Luca, F. D., Camporeale, V., Leccese, G., Cuttano, R., et al. (2026) · Cancers · doi:10.3390/cancers18030414 · Cited by 3
Metadata
- Authors
- Young, A. P., Schlisio, S., Minamishima, Y. A., Zhang, Q., Li, L., Grisanzio, C., Signoretti, S., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- Venue
- Nature Cell Biology
- Published
- 2008-02-24
- Volume
- 10
- Issue
- 3
- Pages
- 361-369
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2158435332
- Cited by
- 239
- References
- 33
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 7 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 17 · 2019: 13 · 2018: 6 · 2017: 7 · 2016: 18 · 2015: 18 · 2014: 20 · 2013: 19 · 2012: 18
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- von Hippel-Lindau protein, VHL loss, cellular senescence, retinoblastoma protein, P400, Skp2, p27, tumor suppression, renal cell carcinoma, ubiquitin ligase
- MeSH terms
- Animals, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Membrane Glycoproteins, Mice, Transgenic, Mutation, Oxygen, Phenotype, Retroviridae, Calcium Channels, Retinoblastoma Protein, Cellular Senescence, Receptors, Cytoplasmic and Nuclear, Mice, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Inositol 1,4,5-Trisphosphate Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.